Global And United States Cancer Testing/Screening Market Report & Forecast 2022-2028

1 Study Coverage
1.1 Cancer Testing/Screening Revenue in Cancer Testing/Screening Business (2017-2022) & (US$ Million) Introduction
1.2 Global Cancer Testing/Screening Outlook 2017 VS 2022 VS 2028
1.2.1 Global Cancer Testing/Screening Market Size for the Year 2017-2028
1.2.2 Global Cancer Testing/Screening Market Size for the Year 2017-2028
1.3 Cancer Testing/Screening Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Cancer Testing/Screening in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Cancer Testing/Screening Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Cancer Testing/Screening Market Dynamics
1.4.1 Cancer Testing/Screening Industry Trends
1.4.2 Cancer Testing/Screening Market Drivers
1.4.3 Cancer Testing/Screening Market Challenges
1.4.4 Cancer Testing/Screening Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Cancer Testing/Screening by Type
2.1 Cancer Testing/Screening Market Segment by Type
2.1.1 Magnetic Resonance Imaging (MRI)
2.1.2 Human Papillomavirus (HPV) Testing
2.1.3 Colonoscopy
2.1.4 Others
2.2 Global Cancer Testing/Screening Market Size by Type (2017, 2022 & 2028)
2.3 Global Cancer Testing/Screening Market Size by Type (2017-2028)
2.4 United States Cancer Testing/Screening Market Size by Type (2017, 2022 & 2028)
2.5 United States Cancer Testing/Screening Market Size by Type (2017-2028)
3 Cancer Testing/Screening by Application
3.1 Cancer Testing/Screening Market Segment by Application
3.1.1 Lung Cancer
3.1.2 Blood Cancer
3.1.3 Bone Cancer
3.1.4 Gall Bladder Cancer
3.1.5 Others
3.2 Global Cancer Testing/Screening Market Size by Application (2017, 2022 & 2028)
3.3 Global Cancer Testing/Screening Market Size by Application (2017-2028)
3.4 United States Cancer Testing/Screening Market Size by Application (2017, 2022 & 2028)
3.5 United States Cancer Testing/Screening Market Size by Application (2017-2028)
4 Global Cancer Testing/Screening Competitor Landscape by Company
4.1 Global Cancer Testing/Screening Market Size by Company
4.1.1 Top Global Cancer Testing/Screening Companies Ranked by Revenue (2021)
4.1.2 Global Cancer Testing/Screening Revenue by Player (2017-2022)
4.2 Global Cancer Testing/Screening Concentration Ratio (CR)
4.2.1 Cancer Testing/Screening Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Cancer Testing/Screening in 2021
4.2.3 Global Cancer Testing/Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Cancer Testing/Screening Headquarters, Revenue in Cancer Testing/Screening Business (2017-2022) & (US$ Million) Type
4.3.1 Global Cancer Testing/Screening Headquarters and Area Served
4.3.2 Global Cancer Testing/Screening Companies Revenue in Cancer Testing/Screening Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Cancer Testing/Screening Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Cancer Testing/Screening Market Size by Company
4.5.1 Top Cancer Testing/Screening Players in United States, Ranked by Revenue (2021)
4.5.2 United States Cancer Testing/Screening Revenue by Players (2020, 2021 & 2022)
5 Global Cancer Testing/Screening Market Size by Region
5.1 Global Cancer Testing/Screening Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Cancer Testing/Screening Market Size by Region (2017-2028)
5.2.1 Global Cancer Testing/Screening Market Size by Region: 2017-2022
5.2.2 Global Cancer Testing/Screening Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Cancer Testing/Screening Market Size YoY Growth 2017-2028
6.1.2 North America Cancer Testing/Screening Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Cancer Testing/Screening Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Cancer Testing/Screening Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Cancer Testing/Screening Market Size YoY Growth 2017-2028
6.3.2 Europe Cancer Testing/Screening Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Cancer Testing/Screening Market Size YoY Growth 2017-2028
6.4.2 Latin America Cancer Testing/Screening Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Cancer Testing/Screening Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Cancer Testing/Screening Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Dias Orin
7.1.1 Dias Orin Company Details
7.1.2 Dias Orin Business Overview
7.1.3 Dias Orin Cancer Testing/Screening Introduction
7.1.4 Dias Orin Revenue in Cancer Testing/Screening Business (2017-2022)
7.1.5 Dias Orin Recent Development
7.2 Epigenetics
7.2.1 Epigenetics Company Details
7.2.2 Epigenetics Business Overview
7.2.3 Epigenetics Cancer Testing/Screening Introduction
7.2.4 Epigenetics Revenue in Cancer Testing/Screening Business (2017-2022)
7.2.5 Epigenetics Recent Development
7.3 Techlab
7.3.1 Techlab Company Details
7.3.2 Techlab Business Overview
7.3.3 Techlab Cancer Testing/Screening Introduction
7.3.4 Techlab Revenue in Cancer Testing/Screening Business (2017-2022)
7.3.5 Techlab Recent Development
7.4 Positive Bioscience
7.4.1 Positive Bioscience Company Details
7.4.2 Positive Bioscience Business Overview
7.4.3 Positive Bioscience Cancer Testing/Screening Introduction
7.4.4 Positive Bioscience Revenue in Cancer Testing/Screening Business (2017-2022)
7.4.5 Positive Bioscience Recent Development
7.5 Genextropy
7.5.1 Genextropy Company Details
7.5.2 Genextropy Business Overview
7.5.3 Genextropy Cancer Testing/Screening Introduction
7.5.4 Genextropy Revenue in Cancer Testing/Screening Business (2017-2022)
7.5.5 Genextropy Recent Development
7.6 M Genomics
7.6.1 M Genomics Company Details
7.6.2 M Genomics Business Overview
7.6.3 M Genomics Cancer Testing/Screening Introduction
7.6.4 M Genomics Revenue in Cancer Testing/Screening Business (2017-2022)
7.6.5 M Genomics Recent Development
7.7 20/20 GeneSystems
7.7.1 20/20 GeneSystems Company Details
7.7.2 20/20 GeneSystems Business Overview
7.7.3 20/20 GeneSystems Cancer Testing/Screening Introduction
7.7.4 20/20 GeneSystems Revenue in Cancer Testing/Screening Business (2017-2022)
7.7.5 20/20 GeneSystems Recent Development
7.8 AB SCIEX
7.8.1 AB SCIEX Company Details
7.8.2 AB SCIEX Business Overview
7.8.3 AB SCIEX Cancer Testing/Screening Introduction
7.8.4 AB SCIEX Revenue in Cancer Testing/Screening Business (2017-2022)
7.8.5 AB SCIEX Recent Development
7.9 Abbott Laboratories
7.9.1 Abbott Laboratories Company Details
7.9.2 Abbott Laboratories Business Overview
7.9.3 Abbott Laboratories Cancer Testing/Screening Introduction
7.9.4 Abbott Laboratories Revenue in Cancer Testing/Screening Business (2017-2022)
7.9.5 Abbott Laboratories Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer

List of Tables
Table 1. Cancer Testing/Screening Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Cancer Testing/Screening Market Trends
Table 3. Cancer Testing/Screening Market Drivers
Table 4. Cancer Testing/Screening Market Challenges
Table 5. Cancer Testing/Screening Market Restraints
Table 6. Global Cancer Testing/Screening Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Cancer Testing/Screening Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Cancer Testing/Screening Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Cancer Testing/Screening Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Cancer Testing/Screening Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Cancer Testing/Screening Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Cancer Testing/Screening Revenue Share by Player, 2017-2022
Table 13. Global Cancer Testing/Screening Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cancer Testing/Screening by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Testing/Screening as of 2021)
Table 15. Top Players of Cancer Testing/Screening in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Cancer Testing/Screening Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Cancer Testing/Screening Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Cancer Testing/Screening Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Cancer Testing/Screening Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Cancer Testing/Screening Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Cancer Testing/Screening Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Cancer Testing/Screening Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Cancer Testing/Screening Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Cancer Testing/Screening Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Cancer Testing/Screening Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Cancer Testing/Screening Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Cancer Testing/Screening Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Cancer Testing/Screening Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Dias Orin Company Details
Table 31. Dias Orin Business Overview
Table 32. Dias Orin Cancer Testing/Screening Product
Table 33. Dias Orin Revenue in Cancer Testing/Screening Business (2017-2022) & (US$ Million)
Table 34. Dias Orin Recent Development
Table 35. Epigenetics Company Details
Table 36. Epigenetics Business Overview
Table 37. Epigenetics Cancer Testing/Screening Product
Table 38. Epigenetics Revenue in Cancer Testing/Screening Business (2017-2022) & (US$ Million)
Table 39. Epigenetics Recent Development
Table 40. Techlab Company Details
Table 41. Techlab Business Overview
Table 42. Techlab Cancer Testing/Screening Product
Table 43. Techlab Revenue in Cancer Testing/Screening Business (2017-2022) & (US$ Million)
Table 44. Techlab Recent Development
Table 45. Positive Bioscience Company Details
Table 46. Positive Bioscience Business Overview
Table 47. Positive Bioscience Cancer Testing/Screening Product
Table 48. Positive Bioscience Revenue in Cancer Testing/Screening Business (2017-2022) & (US$ Million)
Table 49. Positive Bioscience Recent Development
Table 50. Genextropy Company Details
Table 51. Genextropy Business Overview
Table 52. Genextropy Cancer Testing/Screening Product
Table 53. Genextropy Revenue in Cancer Testing/Screening Business (2017-2022) & (US$ Million)
Table 54. Genextropy Recent Development
Table 55. M Genomics Company Details
Table 56. M Genomics Business Overview
Table 57. M Genomics Cancer Testing/Screening Product
Table 58. M Genomics Revenue in Cancer Testing/Screening Business (2017-2022) & (US$ Million)
Table 59. M Genomics Recent Development
Table 60. 20/20 GeneSystems Company Details
Table 61. 20/20 GeneSystems Business Overview
Table 62. 20/20 GeneSystems Cancer Testing/Screening Product
Table 63. 20/20 GeneSystems Revenue in Cancer Testing/Screening Business (2017-2022) & (US$ Million)
Table 64. 20/20 GeneSystems Recent Development
Table 65. AB SCIEX Company Details
Table 66. AB SCIEX Business Overview
Table 67. AB SCIEX Cancer Testing/Screening Product
Table 68. AB SCIEX Revenue in Cancer Testing/Screening Business (2017-2022) & (US$ Million)
Table 69. AB SCIEX Recent Development
Table 70. Abbott Laboratories Company Details
Table 71. Abbott Laboratories Business Overview
Table 72. Abbott Laboratories Cancer Testing/Screening Product
Table 73. Abbott Laboratories Revenue in Cancer Testing/Screening Business (2017-2022) & (US$ Million)
Table 74. Abbott Laboratories Recent Development
Table 75. Research Programs/Design for This Report
Table 76. Key Data Information from Secondary Sources
Table 77. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Testing/Screening Product Picture
Figure 2. Global Cancer Testing/Screening Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Cancer Testing/Screening Market Size 2017-2028 (US$ Million)
Figure 4. United States Cancer Testing/Screening Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Cancer Testing/Screening Market Size 2017-2028 (US$ Million)
Figure 6. United States Cancer Testing/Screening Market Share in Global 2017-2028
Figure 7. Cancer Testing/Screening Report Years Considered
Figure 8. Product Picture of Magnetic Resonance Imaging (MRI)
Figure 9. Product Picture of Human Papillomavirus (HPV) Testing
Figure 10. Product Picture of Colonoscopy
Figure 11. Product Picture of Others
Figure 12. Global Cancer Testing/Screening Market Share by Type in 2022 & 2028
Figure 13. Global Cancer Testing/Screening Market Size by Type (2017-2028) & (US$ Million)
Figure 14. Global Cancer Testing/Screening Market Share by Type (2017-2028)
Figure 15. United States Cancer Testing/Screening Market Share by Type in 2022 & 2028
Figure 16. United States Cancer Testing/Screening Market Size by Type (2017-2028) & (US$ Million)
Figure 17. United States Cancer Testing/Screening Market Share by Type (2017-2028)
Figure 18. Product Picture of Lung Cancer
Figure 19. Product Picture of Blood Cancer
Figure 20. Product Picture of Bone Cancer
Figure 21. Product Picture of Gall Bladder Cancer
Figure 22. Product Picture of Others
Figure 23. Global Cancer Testing/Screening Market Share by Application in 2022 & 2028
Figure 24. Global Cancer Testing/Screening Market Size by Application (2017-2028) & (US$ Million)
Figure 25. Global Cancer Testing/Screening Market Share by Application (2017-2028)
Figure 26. United States Cancer Testing/Screening Market Share by Application in 2022 & 2028
Figure 27. United States Cancer Testing/Screening Market Size by Application (2017-2028) & (US$ Million)
Figure 28. United States Cancer Testing/Screening Market Share by Application (2017-2028)
Figure 29. North America Cancer Testing/Screening Market Size Growth Rate 2017-2028 (US$ Million)
Figure 30. U.S. Cancer Testing/Screening Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. Canada Cancer Testing/Screening Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Europe Cancer Testing/Screening Market Size Growth Rate 2017-2028 (US$ Million)
Figure 33. Germany Cancer Testing/Screening Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. France Cancer Testing/Screening Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. U.K. Cancer Testing/Screening Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Italy Cancer Testing/Screening Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Russia Cancer Testing/Screening Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Asia-Pacific Cancer Testing/Screening Market Size Growth Rate 2017-2028 (US$ Million)
Figure 39. China Cancer Testing/Screening Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Japan Cancer Testing/Screening Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. South Korea Cancer Testing/Screening Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. India Cancer Testing/Screening Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Australia Cancer Testing/Screening Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Taiwan Cancer Testing/Screening Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Indonesia Cancer Testing/Screening Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Thailand Cancer Testing/Screening Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Malaysia Cancer Testing/Screening Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Philippines Cancer Testing/Screening Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Latin America Cancer Testing/Screening Market Size Growth Rate 2017-2028 (US$ Million)
Figure 50. Mexico Cancer Testing/Screening Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Brazil Cancer Testing/Screening Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Argentina Cancer Testing/Screening Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Middle East & Africa Cancer Testing/Screening Market Size Growth Rate 2017-2028 (US$ Million)
Figure 54. Turkey Cancer Testing/Screening Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Cancer Testing/Screening Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 56. UAE Cancer Testing/Screening Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 57. Dias Orin Revenue Growth Rate in Cancer Testing/Screening Business (2017-2022)
Figure 58. Epigenetics Revenue Growth Rate in Cancer Testing/Screening Business (2017-2022)
Figure 59. Techlab Revenue Growth Rate in Cancer Testing/Screening Business (2017-2022)
Figure 60. Positive Bioscience Revenue Growth Rate in Cancer Testing/Screening Business (2017-2022)
Figure 61. Genextropy Revenue Growth Rate in Cancer Testing/Screening Business (2017-2022)
Figure 62. M Genomics Revenue Growth Rate in Cancer Testing/Screening Business (2017-2022)
Figure 63. 20/20 GeneSystems Revenue Growth Rate in Cancer Testing/Screening Business (2017-2022)
Figure 64. AB SCIEX Revenue Growth Rate in Cancer Testing/Screening Business (2017-2022)
Figure 65. Abbott Laboratories Revenue Growth Rate in Cancer Testing/Screening Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.